We’re proud to be part of such a tight-knit community. The more we can stay in touch, the closer we can work together. Click subscribe to receive news and updates about Amylyx.
Lower Long-Term Risk of Death or Permanent Ventilation and First Hospitalization Among Participants with ALS Receiving AMX0035 in the CENTAUR Trial
Lead Author: Sabrina Paganoni, MD, PhD
Published: Muscular Dystrophy Association (MDA)
Date: March 18, 2021
Functional and Long-Term Survival Data of AMX0035 in Amyotrophic Lateral Sclerosis: Results of the CENTAUR Trial
Lead Author: Sabrina Paganoni, MD, PhD
Published: American Society for Experimental Neurotherapeutics (ASENT)
Date: February 23, 2021
Functional and Long-Term Survival Benefit of AMX0035 in ALS: Results of the CENTAUR and Open-Label Extension Trials
Lead Author: Sabrina Paganoni, MD, PhD
Published: International Symposium on ALS-MND (MNDA)
Date: December 9, 2020
Long-Term Survival of Participants in the CENTAUR Trial of Sodium Phenylbutyrate-Taurursodiol in Amyotrophic Lateral Sclerosis
Lead Author: Sabrina Paganoni, MD, PhD
Published: Muscle & Nerve
Date: October 16, 2020
Long-Term Treatment with AMX0035 in the Open-Label Extension of CENTAUR, a Randomized Controlled Trial in Individuals with Amyotrophic Lateral Sclerosis
Lead Author: Sabrina Paganoni, MD, PhD
Published: American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)
Date: October 10, 2020
Accurate Testing of Limb Isometric Strength (ATLIS™) for Measuring Muscle Strength in Amyotrophic Lateral Sclerosis: Results from the CENTAUR Trial
Lead Author: Sabrina Paganoni, MD, PhD
Published: American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)
Date: October 9, 2020
Functional and Long-Term Survival Benefit of AMX0035 in ALS
Lead Author: Sabrina Paganoni, MD, PhD
Published: Northeast ALS Consortium Annual Meeting (NEALS)
Date: September 30, 2020
Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis
Lead Author: Sabrina Paganoni, MD, PhD
Published: New England Journal of Medicine
Date: September 3, 2020
Safety, Efficacy and Pharmacokinetics of Repeat Subcutaneous Dosing of Avexitide (Exendin 9-39) for Treatment of Post-Bariatric Hypoglycaemia
Lead Author: Marilyn Tan, MD, FACE
Published: Diabetes, Obesity and Metabolism
Date: August 1, 2020
Clinical Trial Design for a Phase II, Randomized Placebo-Controlled Trial of AMX0035 in Alzheimer’s Disease
Lead Author: Kent L. Leslie
Published: Alzheimer’s Association International Conference (AAIC)
Date: July 24, 2018